Pharma Industry News

MHRA approves Paion’s ‘ultra-short-acting’ anaesthetic Byfavo

The approval of Byfavo is based on data from a US-based Phase III clinical trial programme in procedural sedationOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]